Myeloid Malignancy Flashcards

1
Q

Where do mutational events occur leading to myeloid malignancies?

A

In haematopoietic stem cell or in the early (more committed) myeloprogenitor cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A mutation in the haemopoetic stem cell leading to leukaemia produced a cell called what?

A

Leukaemic stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two vital jobs of the HPSC?

A

Self-renewal and multipotentiality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is self-renewal different in AML?

A

Early progenitor cells should lose their ability to self-renew in health, but instead they behave more like stem cells due to mutations and are able to self-renew
BUT differentiate is blocked –> population grows replacing the normal haematopoietic stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the features of AML?

A

Bone marrow failure

anaemia, thrombocytopenic bleeding (purpura/mucosal membrane), infection (due to neutropenia, mostly bacterial/fungal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the appearance of the bone marrow in acute leukaemia?

A

Absolutely packed with blast cells (buried within this are leukaemic stem cells driving this)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a big confluent area of thrombocytopenic bleeding in the skin called?

A

Ecchymosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What investigations should you do if you suspect AML?

A

Blood count, blood film (WCC high/low, neutropenia, thrombocytopenia, low Hb)
Bone marrow aspirate (will confirm diagnosis)/trephine
Cryptogenetics (karyotype) from leukaemic balsts
Immunophenotyping of leukaemic blasts (can distinguish between myeloblasts/lymphoblasts)
CSF examination if symptoms (e.g. headache, cranial n palsy)
Targeted molecular genetics for associated acquired gene mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What must you see on bone marrow aspiration to confirm AML diagnosis?

A

> 20% blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What associated acquired gene mutations might you test for?

A

FLT3 (poor prognosis), NPM1 (better prognosis), IDH 1 and 2 (enzymes of kreb cycle that can become leukogenic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you treat AML?

A

Supportive care (platelets, transfusion, antibx, antifungals if needed etc.)
Anti-leukaemic chemotherapy (induction and consolidation)
Use danorubicin and cytosine arabinoside
Allogenic stem cell transplantation (recognises leukaemia as foreign and kills it)
All-trans retinoic acid and arsenic trioxide in low risk acute promyelocytic leukaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What targeted treatments can be used for AML?

A

Midostaurin in FLT3 mutated AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the new targeted antibody treatment in AML?

A

Mylotarg

Binds to CD33 antigen on leukaemic cells, if internalised and releases molecules that damage DNA

But drug pump on leukaemic cell can release these –> damage to other cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is chronic myeloid leukaemia?

A

Mutation in HPSC with excessive proliferation in the myeloid lineage (esp granulocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the features of CML?

A

Anaemia (bone marrow failure, cytokine supressing haemostasis, hepicidin)
Splenomegaly (due to infiltration)
Weight loss (sweat a lot due to huge cell burden)
Hyperleukostasis - fundal haemorrhage, venous congestion, altered consciousness, respiratory failure
Gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why must you not transfuse blood in CML patients?

A

Anaemia is protective as there is hyperleukostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What would be a typical blood count in CML?

A

High WBC, low Hb, often high platelets, high neutrophils and monocytes, eosinophils, basophils etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the appearance of the blood film in CML?

A

lots of white cells, with myelocytes and metamyelocytes

19
Q

What are the lab features of CML?

A

High WCC, platelets, anaemia, blood film with all stages of white cell differentiation with increased basophils
Bone marrow hypercellular
Philadelphia chromosome present

20
Q

What is the Philadelphia chromosome?

A

A translocation between chromosome 9 and 11 leading to a BCR-ABL fusion which is present in a lot of CML

21
Q

What is involved in the treatment of CML?

A

Tyrosine kinase inhibitors, e.g. glivec
(direct inhibitors of the BCR-ABL gene)
Allogenic transplantation in TKI failure

22
Q

How do the tyrosine kinase inhibitors work?

A

ABL-BCR gene activates downstream uncontrolled downstream signalling through phospholyation but the TKIs bind to the kinase domain and block CML essentially

23
Q

What are myelodysplastic syndromes?

A

Acquired clonal disorders of bone marrow

Seen in elderly

24
Q

What is the typical presentation of MDS?

A

Elderly, may present as macrocytic anaemia and pancytopenia

25
Why might we worry about MDS?
They are pre-leukaemic | May be fatal as a result of bone marrow failure or AML (1/3rd progress to AML)
26
How do you treat MDS?
Supportive | Stem cell transplantation for young patients
27
What are the three myeloproliferative neoplasms?
Polycythaemia vera Essential thrombocythaemia Idiopathic myelofibrosis
28
What are the myeloproliferative neoplasms a result of?
Over proliferation of differentiated cells
29
What is PV an excess of?
Red cells
30
What is ET an excess of?
platelets
31
What mutation tends to be present in these myeloproliferative neoplasms?
JAK2 | 95% in PV, 50% in ET and myelofibrosis
32
What is JAK2?
Tyrosine kinase linked to a cell surface receptor Stimulated by no of cytokines, incl. erythropoietin In mutation of JAK2 - doesn't need signal * open all the time, independent on cytokines
33
What are the clinical features of PV?
``` Headaches Itch Vascular occlusion Thrombosis TIA, stroke Splenomegaly (all due to increased viscosity/reduced O2 delivery) ```
34
What are the lab features of PV?
Raised Hb and haematocrit Tend to also have raised WCC/platelets Raised uric acid Inc. in red cell mass
35
What is haematocrit?
% of blood that is red cells | usually 45%
36
What anaemia are patients with PV at risk of?
Iron deficiency anaemia
37
How do you treat PV?
Venesection and aspirin ``` ?hydroxycarbamide JAK2 inhibitors (e.g. ruxolitinib) if HC failure and systemic symptoms ```
38
What is the natural history of PV?
Stroke/venous thromboses if poorly controlled Bone marrow failure from development of secondary myelofibrosis Transformation to AML NB - if really high risk will need treatment with HC etc.
39
What is ET?
Myeloproliferative disease with predominant feature of raised platelet count
40
What mutations tend to occur in ET?
JAK3 (50%) | CALR (calreticulin) 25%
41
What symptoms are associated with ET?
Arterial/venous thromboses, digital ischaemia, gout, headache, splenomegaly
42
How do you treat ET?
Aspirin, hydroxycardbamide or anagrelide (platelet inhibitor)
43
What can ET progress to?
Myelofibrosis/AML